Aayush Wellness is currently trading at Rs. 284.00, up by 3.75 points or 1.34% from its previous closing of Rs. 280.25 on the BSE.
The scrip opened at Rs. 286.00 and has touched a high and low of Rs. 286.00 and Rs. 280.00 respectively. So far 428 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 313.95 on 26-Jun-2024 and a 52 week low of Rs. 21.11 on 14-Aug-2023.
Last one week high and low of the scrip stood at Rs. 309.40 and Rs. 275.50 respectively. The current market cap of the company is Rs. 92.16 crore.
The Non-Institutions held 100.00% stake in the company.
Aayush Wellness has introduced new portal ‘www.aayushwellness.com’ to enhance accessibility of its products and services, pan India. This strategic move is designed to extend the availability of Aayush Wellness products and services to every corner of the country, ensuring that even the most remote and underserved areas can benefit from high-quality health and wellness solutions.
Over the years, the company has established itself as a trusted provider of high-quality foodoriented products and supplements. The company is committed to promoting holistic wellbeing and making its products and services accessible to a broader audience. With the increasing demand for integrated wellness solutions, the company recognized the need to broaden its scope and cater to the evolving needs of its customers from metros to remote areas. The launch of the online platform is a significant milestone in this journey. By leveraging cutting-edge e-commerce technology and a robust distribution network, the company is poised to bridge the gap between urban and rural preventive healthcare access.
Aayush Wellness (formerly known as Aayush Food and Herbs ) is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: